T Regulatory and Childhood Asthma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00204828
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
  Purpose

This is an epidemiologic study, examining environmental exposures and affect on immune development.


Condition
Childhood Asthma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: T Regulatory and Childhood Asthma

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Childhood asthma [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • Allergic sensitization [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

blood, PBMC culture supes and nasal lavage


Enrollment: 58
Study Start Date: October 2005
Estimated Study Completion Date: December 2013
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1.
Children with asthma
2.
Children without asthma

Detailed Description:

This is an epidemiologic study, examining environmental exposures and affect on immune development. The study has completed enrollment

  Eligibility

Ages Eligible for Study:   6 Years to 7 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

6-7 yo children of either gender

Criteria

Inclusion Criteria:

  • moderate to severe asthma

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204828

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: James Gern, MD University of Wisconsin, Madison
  More Information

Additional Information:
No publications provided

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00204828     History of Changes
Other Study ID Numbers: 2004-0224, RO1 HL080072
Study First Received: September 12, 2005
Last Updated: December 12, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 24, 2014